http___metro-portal.hr_otkriveno-cjepivo-protiv-herpesa_67074_1.xml
1.1 1.2 2.1 3.1 4.1 5.1 6.1 7.1 7.2 8.1
*Good Lord! Talk about news you can use … The CDC claims that nearly half (48 percent) of all African American women between the ages of 14 and 49 are infected with genital herpes. Black women have the highest rate of infection and their rate is nearly twice as high as men. About 16 percent of Americans between the ages of 14 and 49 are infected with genital herpes, making it one of the most common sexually transmitted diseases, U.S. health officials said on Tuesday. Black women had the highest rate of infection at 48 percent and women were nearly twice likely as men to be infected, according to an analysis by the U.S. Centers for Disease Control and Prevention. About 21 percent of women were infected with genital herpes, compared to only 11.5 percent of men, while 39 percent of blacks were infected compared to about 12 percent for whites, the CDC said. There is no cure for genital herpes, or herpes simplex virus type 2 (HSV-2), which can cause recurrent and painful genital sores and also increases the likelihood of acquiring and transmitting the AIDS virus. It is related to herpes simplex virus 1, or oral herpes, which causes cold sores. Read/learn more about this sobering at Reuters.
1.1 2.1 3.1 3.2 4.1 4.2 5.1 5.2 6.1
Otkriveno cjepivo protiv herpesa Pretpostavlja se da je herpesom tip 1 zaraženo oko 90 posto ljudi starijih od 50 godina, a znanstvenici su konačno pronašli cjepivo koje bi moglo protiv sproječiti dosada neizlječivu bolesti Tim znanstvenika sa sveučilišta St. Louis napravili su ogroman korak u razvijanju efektivnog cjepiva protiv jednog oblika herpesa, a rezultate istraživanja su objavili u stručnom glasilu New England Journal of Medicine, piše Private MD Labs. U izvješću stoji da su znanstvenici kreirali cjepivo koje imam parcijalni efekt u sprječavanju zaraze virusom herpes simplex tip 1, koji se najčešće manifestira kao oteklina na usnici. Cjepivo nije u stanju spriječiti infekciju herpesom simplexom tip 2, iliti genitalnim herpesom, ali znanstvenici tvrde da su rezultati studije potvrdili kako su na dobrom putu. „Ovo je veliki korak pri kreiranju funkcionalnog cjepiva protiv spolne bolesti uzrokovane virusom herpesa. Na dobrom smo putu da u bliskoj budućnosti napravimo cjepivo koje će biti djelotvorno na oba tipa herpesa", rekao je Robert Belshe, voditelji istraživanja. Herpes simplex tip 2, odnosno HSV-2 iliti genitalni herpes, manifestira se u obliku mjehurića na genitalijama, a pošto nema lijeka prevencija je najbolji način zaštite.